BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer
Jiahui Zhang(University of Science and Technology of China), Wenchu Lin(Chinese University of Hong Kong, Shenzhen)
Cited by 10
Related Papers
Exosomal miR-92b-3p Promotes Chemoresistance of Small Cell Lung Cancer Through the PTEN/AKT Pathway
|Frontiers in Cell and Developmental Biology|2021|46
The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
|Journal of Experimental & Clinical Cancer Research|2020|46
FK228 potentiates topotecan activity against small cell lung cancer cells via induction of SLFN11
|Acta Pharmacologica Sinica|2021|25
FK228 sensitizes radioresistant small cell lung cancer cells to radiation
|Clinical Epigenetics|2021|17
Combinations of proteasome inhibitors with obatoclax are effective for small cell lung cancer
|Acta Pharmacologica Sinica|2020|12